Dentistry

Atopic dermatitis is a skin inflammation caused by sensitivity to something in the environment. It often runs in families and may occur along with hay fever,...  

 

A 62 year old woman presented to eye casualty with a 10 day history of a left sided headache. Two days after her headache started she developed a painful and pruritic left sided rash. During the 24 hours before presentation, her left eye had become injected, painful, and photophobic.  

The likelihood that a woman will take pills to keep her breast cancer from coming back is higher if she tended to consistently take medications as directed in the past, a new study found.  

A new cancer drug can significantly slow the spread of deadly recurrent breast cancers, a study shows.  

Long-term use of cannabis is associated with a significant increase in the risk of developing gum disease but does not appear to be linked to other adverse health outcomes, new data suggest.  

A pressure ulcer is a sore that results from the death of the skin and its underlying tissue in areas of the body that receive pressure. This occurs when a p...  

At ASCO 2016, the results of the ABC suite of trials provided guidance on a very important clinical question in breast cancer management.  

A major clinical trial indicates that 5 more years of an aromatase inhibitor in postmenopausal women yields a disease-free survival benefit as well as adverse events. Is the treatment worthwhile?  

A new cancer drug can significantly slow the spread of deadly recurrent breast cancers, a study shows.  

Extending use of adjuvant aromatase inhibitors from five to 10 years in women treated for primary breast cancer significantly increases rates of disease-free survival and the risk of cancer occurring in the other breast, a study published in the New England Journal of Medicine shows.1 However, extended use of the drugs was not found to affect overall survival.  

Taking hormonal drugs for up to 15 years reduces the risk of breast cancers coming back, a landmark study suggests.  

Many oncology clinical trials fail to complete enrollment, but a new study of metastatic breast cancer has patients signing up in droves. What is going on?  

Reports of serious burns and scarring with the use of the Zecuity sumatriptan transdermal patch for migraine prompts FDA investigation and drug safety communication.  

Abscess is a common presenting complaint in the emergency department. Most abscesses can be managed with simple incision and drainage. Is there an alternative to I & D? What are some indications to consult a surgeon for drainage in the operating room? And when should antibiotics be prescribed? This post will explore current topics in management of abscess in the emergency department.   

Babies exposed to hard water may have a higher risk of developing the skin condition eczema than those who live in areas of the country with soft water, according to a UK study.  

A just-published trial suggests the oral plasma-kallikrein inhibitor avoralstat may cut the frequency of attacks in patients with severe hereditary angioedema (HAE). But as-yet-unpublished data from a subsequent, larger study dash those hopes, at least for the liquid formulation.  

Researchers have called for clinical trials into the effects of statins in women with recurrent breast cancer, after finding that these cancers can make a molecule from cholesterol that mimics oestrogen.  

ASCO has a new guideline for the use of endocrine therapy in patients with hormone-receptor-positive metastatic breast cancer.  

Two GPs who were prosecuted for the manslaughter of a 12 year old patient have been acquitted after the judge presiding over the trial at Cardiff Crown Court ruled that there was no case for them to answer.